» Articles » PMID: 29989513

A Novel SLC1A4 Homozygous Mutation Causing Congenital Microcephaly, Epileptic Encephalopathy and Spastic Tetraparesis: a Video-EEG and Tractography - Case Study

Overview
Journal J Neurogenet
Publisher Informa Healthcare
Specialties Genetics
Neurology
Date 2018 Jul 11
PMID 29989513
Citations 9
Authors
Affiliations
Soon will be listed here.
Abstract

Biallelic mutations in the SLC1A4 gene have been identified as a very rare cause of neurodevelopmental disorders. l-serine transport deficiency has been regarded as the causal molecular mechanism underlying the neurological phenotype of SLC1A4 mutation patients. To date this genetic condition has been reported almost exclusively in a limited number of Ashkenazi-Jewish individuals and as a result the SLC1A4 gene is not routinely included in the majority of the genetic diagnostic panels for neurological diseases. We hereby report a 7-year-old boy from a Southern Italian family, presenting with epileptic encephalopathy, congenital microcephaly, global developmental delay, severe hypotonia, spasticity predominant at the lower limbs, and thin corpus callosum. Whole exome sequencing identified a novel segregating SLC1A4 gene homozygous mutation (c.1141G > A: p.Gly381Arg) as the likely cause of the disease in our family. In order to deeply characterize the electro-clinical and neurological phenotype in our index patient, long-term systematic video-electroencephalograms (EEG) as well as repeated brain imaging studies (which included tractographic reconstructions) were performed on a regular basis during a 7 years follow-up time. In conclusion, we suggest to carefully considering SLC1A4 biallelic mutations in individuals presenting an early onset severe neurodevelopmental disorder with variable spasticity and seizures, regardless the patients' ethnic background.

Citing Articles

SLC1A4 and Serine Homeostasis: Implications for Neurodevelopmental and Neurodegenerative Disorders.

Elazar D, Alvarez N, Drobeck S, Gunn T Int J Mol Sci. 2025; 26(5).

PMID: 40076728 PMC: 11900201. DOI: 10.3390/ijms26052104.


A new type of blood-brain barrier aminoacidopathy underlies metabolic microcephaly associated with SLC1A4 mutations.

Odeh M, Sajrawi C, Majcher A, Zubedat S, Shaulov L, Radzishevsky A Brain. 2024; 147(11):3874-3889.

PMID: 38662784 PMC: 11531853. DOI: 10.1093/brain/awae134.


Generation and characterization of a knock-in mouse model for spastic tetraplegia, thin corpus callosum, and progressive microcephaly (SPATCCM).

Ratz-Mitchem M, Leary G, Grindeland A, Silvius D, Guter J, Kavanaugh M Mamm Genome. 2023; 34(4):572-585.

PMID: 37642681 PMC: 10680402. DOI: 10.1007/s00335-023-10013-4.


Dominant-negative variant in SLC1A4 causes an autosomal dominant epilepsy syndrome.

Pujol-Gimenez J, Mirzaa G, Blue E, Albano G, Miller D, Allworth A Ann Clin Transl Neurol. 2023; 10(6):1046-1053.

PMID: 37194416 PMC: 10270265. DOI: 10.1002/acn3.51786.


Generation and characterization of a knock-in mouse model for Spastic Tetraplegia, Thin Corpus Callosum, and Progressive Microcephaly (SPATCCM).

Ratz M, Leary G, Grindeland A, Silvius D, Guter J, Kavanaugh M Res Sq. 2023; .

PMID: 37162879 PMC: 10168478. DOI: 10.21203/rs.3.rs-2839029/v1.